Biopharmaceutical manufacturer Pfizer announced on May 19 that it will begin production of a component of its COVID-19 at its facility in Ireland.
“Pfizer is now bringing on additional European-based facility to be a part of the global Pfizer-BioNTech COVID-19 vaccine supply chain network and Grange Castle (Ireland) will contribute to the worldwide supply of the vaccine,” the American company said in a statement.
Pfizer said it will produce the “mRNA drug substance” of its vaccine with its partner BioNTech at the facility in west Dublin by the end of the year.
Pfizer also said that the investment to the vaccine production facility reaches up to $40 million and will create 75 new jobs.
Pfizer and BioNTech have made several enhancements to the vaccine supply chain, including “expanding their existing facilities, adding more suppliers, and bringing on additional Pfizer/BioNTech sites and contract manufacturers around the world,” Pfizer also announced.
Taoiseach Michael Martin said that the move “puts Ireland at the heart” of the European Union’s fight against the pandemic.